More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab

 
• By Anju Ghangurde
  
Rio
MYLAN-BIOCON HAVE RECEIVED APPROVAL FOR THEIR HERCEPTIN BIOSIMILAR IN BRAZIL

More from Business

More from Generics Bulletin